loadpatents
name:-0.063454151153564
name:-0.044105052947998
name:-0.0083098411560059
Dylla; Scott J. Patent Filings

Dylla; Scott J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dylla; Scott J..The latest application filed is for "anti sez6 antibodies and methods of use".

Company Profile
8.51.74
  • Dylla; Scott J. - Emerald Hills CA
  • DYLLA; SCOTT J. - MENLO PARK CA
  • Dylla; Scott J. - Mountain View CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Light chain variable regions
Grant 11,033,634 - Stull , et al. June 15, 2
2021-06-15
Anti-PTK7 antibodies and methods of use
Grant 10,836,831 - Foord , et al. November 17, 2
2020-11-17
Anti Sez6 Antibodies And Methods Of Use
App 20200181256 - SAUNDERS; LAURA ;   et al.
2020-06-11
Dll3 Modulators And Methods Of Use
App 20200138969 - Stull; Robert A. ;   et al.
2020-05-07
Anti SEZ6 antibodies and methods of use
Grant 10,533,051 - Saunders , et al. Ja
2020-01-14
Dll3 Modulators And Methods Of Use
App 20190247510 - STULL; ROBERT A. ;   et al.
2019-08-15
Dll3 Modulators And Methods Of Use
App 20190046656 - STULL; ROBERT A. ;   et al.
2019-02-14
Novel Anti-mmp16 Antibodies And Methods Of Use
App 20190022242 - ROY; SOMDUTTA ;   et al.
2019-01-24
Anti-DLL3 antibody drug conjugates for treating cancer
Grant 10,137,204 - Stull , et al. November 27, 2
2018-11-27
Anti-efna4 Antibody-drug Conjugates
App 20180296691 - DAMELIN; Marc Isaac ;   et al.
2018-10-18
Anti-CD324 monoclonal antibodies and uses thereof
Grant 10,087,258 - Stull , et al. October 2, 2
2018-10-02
Anti-dll3 Antibody Drug Conjugates And Methods Of Use
App 20180243435 - DYLLA; SCOTT J. ;   et al.
2018-08-30
Novel Modulators And Methods Of Use
App 20180237512 - HAMPL; JOHANNES ;   et al.
2018-08-23
Novel Modulators And Methods Of Use
App 20180162952 - FOORD; ORIT ;   et al.
2018-06-14
Modulators and methods of use
Grant 9,969,798 - Hampl , et al. May 15, 2
2018-05-15
Identification and enrichment of cell subpopulations
Grant 9,945,842 - Dylla , et al. April 17, 2
2018-04-17
Anti-DLL3 antibody drug conjugates and methods of use
Grant 9,937,268 - Stull , et al. April 10, 2
2018-04-10
Anti-ptk7 Antibody-drug Conjugates
App 20180094075 - DAMELIN; Marc Isaac ;   et al.
2018-04-05
Methods of making DLL3 antibody drug conjugates
Grant 9,931,420 - Stull , et al. April 3, 2
2018-04-03
Methods of delivering DLL3 antibody drug conjugates
Grant 9,931,421 - Stull , et al. April 3, 2
2018-04-03
PTK7 modulators and methods of use
Grant 9,914,784 - Foord , et al. March 13, 2
2018-03-13
Identification And Enrichment Of Cell Subpopulations
App 20180067120 - DYLLA; SCOTT J. ;   et al.
2018-03-08
Anti-dll3 Chimeric Antigen Receptors And Methods Of Use
App 20180044415 - ESCARPE; PAUL ANTHONY ;   et al.
2018-02-15
Methods Of Delivering Dll3 Antibody Drug Conjugates
App 20180036422 - STULL; ROBERT A. ;   et al.
2018-02-08
Methods Of Making Dll3 Antibody Drug Conjugates
App 20180036421 - STULL; ROBERT A. ;   et al.
2018-02-08
Methods of delivering DLL3 antibody drug conjugates
Grant 9,878,053 - Stull , et al. January 30, 2
2018-01-30
Anti-EFNA4 antibody-drug conjugates
Grant 9,872,922 - Damelin , et al. January 23, 2
2018-01-23
Anti-dll3 Antibody Drug Conjugates And Methods Of Use
App 20180015178 - STULL; ROBERT A. ;   et al.
2018-01-18
Anti-DLL3 antibody drug conjugates
Grant 9,867,887 - Stull , et al. January 16, 2
2018-01-16
Kits containing DLL3 antibody drug conjugates
Grant 9,861,708 - Stull , et al. January 9, 2
2018-01-09
Anti-DLL3 antibody drug conjugates
Grant 9,855,343 - Stull , et al. January 2, 2
2018-01-02
Anti Sez6 Antibodies And Methods Of Use
App 20170369571 - SAUNDERS; LAURA ;   et al.
2017-12-28
Anti-dll3 Antibody Drug Conjugates
App 20170368195 - STULL; ROBERT A. ;   et al.
2017-12-28
Anti-cldn Chimeric Antigen Receptors And Methods Of Use
App 20170334991 - ESCARPE; PAUL ANTHONY ;   et al.
2017-11-23
Kits Containing Dll3 Antibody Drug Conjugates
App 20170307622 - STULL; ROBERT A. ;   et al.
2017-10-26
Anti-DLL3 antibody drug conjugates for treating cancer
Grant 9,775,916 - Stull , et al. October 3, 2
2017-10-03
Identification and enrichment of cell subpopulations
Grant 9,778,264 - Dylla , et al. October 3, 2
2017-10-03
Anti-PTK7 antibody-drug conjugates
Grant 9,777,070 - Damelin , et al. October 3, 2
2017-10-03
Dll3 Modulators And Methods Of Use
App 20170274094 - STULL; ROBERT A. ;   et al.
2017-09-28
Anti-DLL3 antibody drug conjugates
Grant 9,770,518 - Stull , et al. September 26, 2
2017-09-26
Methods Of Making Dll3 Antibody Drug Conjugates
App 20170266314 - STULL; ROBERT A. ;   et al.
2017-09-21
Anti-dll3 Antibody Drug Conjugates
App 20170266312 - STULL; ROBERT A. ;   et al.
2017-09-21
Methods Of Delivering Dll3 Antibody Drug Conjugates
App 20170266313 - STULL; ROBERT A. ;   et al.
2017-09-21
Anti-dll3 Antibody Drug Conjugates For Treating Cancer
App 20170266315 - STULL; ROBERT A. ;   et al.
2017-09-21
Modulators and methods of use
Grant 9,765,136 - Hampl , et al. September 19, 2
2017-09-19
Methods of making DLL3 antibody drug conjugates
Grant 9,764,042 - Stull , et al. September 19, 2
2017-09-19
Anti SEZ6 antibodies and methods of use
Grant 9,676,850 - Saunders , et al. June 13, 2
2017-06-13
Anti-cd324 Monoclonal Antibodies And Uses Thereof
App 20170121416 - STULL; Robert A. ;   et al.
2017-05-04
Novel Modulators And Methods Of Use
App 20170081419 - Dylla; Scott J. ;   et al.
2017-03-23
Novel Anti-rnf43 Antibodies And Methods Of Use
App 20170073430 - BOONTANRART; MANDY ;   et al.
2017-03-16
Anti-efna4 Antibody-drug Conjugates
App 20170072066 - DAMELIN; Marc Isaac ;   et al.
2017-03-16
Dll3 Modulators And Methods Of Use
App 20170000901 - STULL; Robert A. ;   et al.
2017-01-05
Anti-CD324 monoclonal antibodies and uses thereof
Grant 9,534,058 - Stull , et al. January 3, 2
2017-01-03
Anti-DLL3 antibody drug conjugates
Grant 9,481,727 - Stull , et al. November 1, 2
2016-11-01
Anti-DLL3 antibody drug conjugates
Grant 9,480,757 - Stull , et al. November 1, 2
2016-11-01
Modulators and methods of use
Grant 9,458,231 - Dylla , et al. October 4, 2
2016-10-04
Novel Modulators And Methods Of Use
App 20160272723 - FOORD; ORIT ;   et al.
2016-09-22
Novel Modulators And Methods Of Use
App 20160264653 - HAMPL; JOHANNES ;   et al.
2016-09-15
Novel Modulators And Methods Of Use
App 20160257745 - HAMPL; JOHANNES ;   et al.
2016-09-08
Anti-DLL3 antibody drug conjugates
App 20160251431 - STULL; Robert A. ;   et al.
2016-09-01
Anti-DLL3 antibody drug conjugates
App 20160250348 - STULL; Robert A. ;   et al.
2016-09-01
Anti-DLL3 antibody drug conjugates
App 20160228571 - STULL; Robert A. ;   et al.
2016-08-11
PTK7 modulators and methods of use
Grant 9,409,995 - Foord , et al. August 9, 2
2016-08-09
Anti-EFNA4 antibody-drug conjugates
Grant 9,381,205 - Damelin , et al. July 5, 2
2016-07-05
Kits Containing Dll3 Antibody Drug Conjugates
App 20160158379 - Stull; Robert A. ;   et al.
2016-06-09
Methods of making DLL3 antibody drug conjugates
Grant 9,358,304 - Stull , et al. June 7, 2
2016-06-07
Methods Of Delivering Dll3 Antibody Drug Conjugates
App 20160151513 - Stull; Robert A. ;   et al.
2016-06-02
Anti-DLL3 antibodies
Grant 9,353,182 - Stull , et al. May 31, 2
2016-05-31
Kits containing DLL3 antibody drug conjugates
Grant 9,352,051 - Stull , et al. May 31, 2
2016-05-31
Methods of delivering DLL3 antibody drug conjugates
Grant 9,345,784 - Stull , et al. May 24, 2
2016-05-24
Methods Of Making Dll3 Antibody Drug Conjugates
App 20160136296 - STULL; Robert A. ;   et al.
2016-05-19
Multivalent Dll3 Antibodies
App 20160130331 - Stull; Robert A. ;   et al.
2016-05-12
Multivalent DLL3 antibodies
Grant 9,334,318 - Stull , et al. May 10, 2
2016-05-10
Modulators and methods of use
Grant 9,320,812 - Hampl , et al. April 26, 2
2016-04-26
Dll3 Modulators And Methods Of Use
App 20160075779 - STULL; Robert A. ;   et al.
2016-03-17
Anti-cd324 Monoclonal Antibodies And Uses Thereof
App 20150337048 - STULL; Robert A. ;   et al.
2015-11-26
Anti-dll3 Antibody Drug Conjugates
App 20150328332 - STULL; ROBERT A. ;   et al.
2015-11-19
Notum Protein Modulators And Methods Of Use
App 20150322166 - STULL; Robert A. ;   et al.
2015-11-12
Anti-ptk7 Antibody-drug Conjugates
App 20150315293 - DAMELIN; Marc Isaac ;   et al.
2015-11-05
Anti-DLL3 antibody drug conjugates
Grant 9,173,959 - Stull , et al. November 3, 2
2015-11-03
Anti-DLL3 antibody drug conjugates and methods of use
Grant 9,155,803 - Stull , et al. October 13, 2
2015-10-13
Anti-dll3 Antibody Drug Conjugates And Methods Of Use
App 20150265724 - Stull; Robert A. ;   et al.
2015-09-24
Anti-DLL3 antibody drug conjugates and methods of use
Grant 9,133,271 - Stull , et al. September 15, 2
2015-09-15
Anti-DLL3 antibody drug conjugates for treating cancer
Grant 9,107,961 - Stull , et al. August 18, 2
2015-08-18
Anti-DLL3 antibodies
Grant 9,089,615 - Stull , et al. July 28, 2
2015-07-28
Anti-DLL3 antibody drug conjugates
Grant 9,089,617 - Stull , et al. July 28, 2
2015-07-28
Anti-DLL3 antibody drug conjugates and methods of use
Grant 9,089,616 - Stull , et al. July 28, 2
2015-07-28
Methods of detection, diagnosis, and monitoring using anti-DLL3 antibodies
Grant 9,090,683 - Stull , et al. July 28, 2
2015-07-28
Anti-efna4 Antibody-drug Conjugates
App 20150125472 - DAMELIN; Marc Isaac ;   et al.
2015-05-07
Nucleic acid encoding DLL3 antibodies
Grant 8,986,972 - Stull , et al. March 24, 2
2015-03-24
Identification And Enrichment Of Cell Subpopulations
App 20150030636 - DYLLA; SCOTT J. ;   et al.
2015-01-29
Anti Sez6 Antibodies And Methods Of Use
App 20150018531 - Saunders; Laura ;   et al.
2015-01-15
Dll3 Modulators And Methods Of Use
App 20140370037 - STULL; ROBERT A. ;   et al.
2014-12-18
Dll3 Modulators And Methods Of Use
App 20140363826 - STULL; ROBERT A. ;   et al.
2014-12-11
Dll3 Modulators And Methods Of Use
App 20140364593 - STULL; ROBERT A. ;   et al.
2014-12-11
Dll3 Modulators And Methods Of Use
App 20140364590 - STULL; ROBERT A. ;   et al.
2014-12-11
Dll3 Modulators And Methods Of Use
App 20140363455 - STULL; ROBERT A ;   et al.
2014-12-11
Dll3 Modulators And Methods Of Use
App 20140363887 - STULL; ROBERT A. ;   et al.
2014-12-11
Novel Modulators And Methods Of Use
App 20140302034 - Bankovich; Alex ;   et al.
2014-10-09
Novel Modulators And Methods Of Use
App 20140105888 - Foord; Orit ;   et al.
2014-04-17
Novel Modulators And Methods Of Use
App 20140093495 - Hampl; Johannes ;   et al.
2014-04-03
Novel Modulators And Methods Of Use
App 20130302355 - Dylla; Scott J. ;   et al.
2013-11-14
Identification And Enrichment Of Cell Subpopulations
App 20130260385 - Dylla; Scott J. ;   et al.
2013-10-03
Notum Protein Modulators And Methods Of Use
App 20130224191 - Stull; Robert A. ;   et al.
2013-08-29
Determining the capability of a test compound to affect solid tumor stem cells
Grant 8,420,885 - Clarke , et al. April 16, 2
2013-04-16
Novel Modulators and Methods of Use
App 20130058947 - Stull; Robert A. ;   et al.
2013-03-07
Identification and Enrichment of Cell Subpopulations
App 20130061340 - Dylla; Scott J. ;   et al.
2013-03-07
Identification and Enrichment of Cell Subpopulations
App 20130061342 - Dylla; Scott J. ;   et al.
2013-03-07
Determining The Capability Of A Test Compound To Affect Solid Tumor Stem Cells
App 20120027685 - Clarke; Michael F. ;   et al.
2012-02-02
Determining the capability of a test compound to affect solid tumor stem cells
Grant 8,044,259 - Clarke , et al. October 25, 2
2011-10-25
Isolation And Use Of Solid Tumor Stem Cells
App 20080178305 - Clarke; Michael F. ;   et al.
2008-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed